The 11 references without contexts in paper , статья Редакционная (2014) “Новая классификация идиопатических интерстициальных пневмоний: совместный документ Американского торакального и Европейского респираторного обществ // Novel classification of idiopathic interstitial pneumonias: statement of American Thoracic Society / European Respiratory Society” / spz:neicon:pulmonology:y:2013:i:5:p:9-24

155
Takahashi H., Fujishima T., Koba H. et al. Serum surfactant proteins A and D as prognostic factors in idiopathic pulmonary fibrosis and their relationship to disease extent. Am. J. Respir. Crit. Care Med. 2000; 162: 1109–1114.
(check this in PDF content)
156
Greene K.E., King T.E., Kuroki Y. et al.Serum surfactant proteins-A and -D as biomarkers in idiopathic pulmonary fibrosis. Eur. Respir. J. 2002; 19: 439–446.
(check this in PDF content)
157
Yokoyama A., Kondo K., Nakajima M. et al.Prognostic value of circulating KL-6 in idiopathic pulmonary fibrosis. Respirology 2006; 11: 164–168.
(check this in PDF content)
158
Takahashi H., Shiratori M., Kanai A. et al. Monitoring markers of disease activity for interstitial lung diseases with serum surfactant proteins A and D. Respirology 2006; 11: S51–S54.
(check this in PDF content)
159
Daniil Z.D., Papageorgiou E., Koutsokera A. et al.Serum levels of oxidative stress as a marker of disease severity in idiopathic pulmonary fibrosis. Pulm. Pharmacol. Ther. 2008; 21: 26–31.
(check this in PDF content)
160
Rosas I.O., Richards T.J., Konishi K. et al. MMP1 and MMP7 as American Thoracic Society Documents 747 potential peripheral blood biomarkers in idiopathic pulmonary fibrosis. PLoS Med. 2008; 5: e93.
(check this in PDF content)
161
Gilani S.R., Vuga L.J., Lindell K.O. et al. CD28 down-regulation on circulating CD4 T-cells is associated with poor prognoses of patients with idiopathic pulmonary fibrosis. PLoS One 2010; 5: e8959.
(check this in PDF content)
162
Richards T.J., Kaminski N., Baribaud F. et al.Peripheral blood proteins predict mortality in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2012; 185: 67–76.
(check this in PDF content)
163
McKeown S., Richter A.G., O'Kane C. et al. MMP expression and abnormal lung permeability are important determinants of outcome in IPF. Eur. Respir. J. 2009; 33: 77–84.
(check this in PDF content)
164
Shinoda H., Tasaka S., Fujishima S. et al.Elevated CC chemokine level in bronchoalveolar lavage fluid is predictive of a poor outcome of idiopathic pulmonary fibrosis. Respiration 2009; 78: 285–292.
(check this in PDF content)
165
Richter A.G., McKeown S., Rathinam S. et al. Soluble endostatin is a novel inhibitor of epithelial repair in idiopathic pulmonary fibrosis. Thorax 2009; 64: 156–161. Поступила 12.11.13 УДК 616.24!002
(check this in PDF content)